IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $15,483,000 | +42.7% | 1,359,331 | +12.7% | 1.56% | +51.3% |
| Q3 2020 | $10,847,000 | -5.2% | 1,205,944 | +8.7% | 1.03% | +38.6% |
| Q2 2020 | $11,446,000 | +3.4% | 1,109,137 | +1.1% | 0.75% | -23.3% |
| Q1 2020 | $11,071,000 | +135.4% | 1,097,232 | +210.5% | 0.97% | +152.7% |
| Q4 2019 | $4,703,000 | -20.3% | 353,362 | -48.6% | 0.38% | -4.5% |
| Q3 2019 | $5,898,000 | +242.3% | 686,954 | +439.4% | 0.40% | +176.0% |
| Q1 2019 | $1,723,000 | +0.6% | 127,364 | -23.0% | 0.15% | -13.6% |
| Q4 2018 | $1,713,000 | – | 165,348 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
| Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
| Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
| Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
| 13D Management LLC | 650,455 | $8,371,000 | 2.88% |
| BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
| Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
| Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
| Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
| PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |